Would you have Skin Rash when you have Multiple Sclerosis?

Summary

Skin rash is found among people with Multiple sclerosis, especially for people who are female, 40-49 old, take medication Tysabri and have Multiple sclerosis. We study 3,416 people who have Skin rash and Multiple sclerosis from FDA and social media. Find out below who they are, other conditions they have and drugs they take.

You are not alone

Join a support group for people who have Multiple sclerosis and Skin rash >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Multiple Sclerosis

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) can be treated by Copaxone, Avonex, Tysabri, Rebif, Baclofen (latest reports from 215,630 Multiple sclerosis patients)

Skin Rash

Skin rash has been reported by people with breathing difficulty, rashes, renal failure acute, abdominal pain, diarrhea (latest reports from 142,134 Skin rash patients).

On Jul, 27, 2016

3,416 people who have Multiple Sclerosis and Skin Rash are studied.


Number of reports submitted per year:

Would you have Skin rash when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experience Skin Rash *:

  • female: 80.38 %
  • male: 19.62 %

Age of people who have Multiple Sclerosis and experience Skin Rash *:

  • 0-1: 0.0 %
  • 2-9: 0.16 %
  • 10-19: 0.62 %
  • 20-29: 7.62 %
  • 30-39: 20.18 %
  • 40-49: 30.73 %
  • 50-59: 28.03 %
  • 60+: 12.66 %

Severity if Multiple Sclerosis and experience Skin Rash *:

  • least: 15.38 %
  • moderate: 46.15 %
  • severe: 38.46 %
  • most severe: 0.0 %

Top co-existing conditions for these people *:

  • Multiple Sclerosis (3,424 people)
  • Depression (78 people)
  • Hypertension (59 people)
  • Pain (45 people)
  • Anxiety (43 people)
  • Muscle Spasms (38 people)
  • Insomnia (24 people)
  • Fatigue (24 people)
  • Multiple Sclerosis Relapse (21 people)
  • Osteoporosis (19 people)

Most common drugs for these people *:

  • Tysabri (1,623 people)
  • Avonex (863 people)
  • Rebif (368 people)
  • Copaxone (257 people)
  • Gilenya (242 people)
  • Betaseron (153 people)
  • Baclofen (150 people)
  • Benadryl (80 people)
  • Provigil (76 people)
  • Neurontin (75 people)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Skin rash and Multiple sclerosis?

Browse all symptoms of Multiple sclerosis

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Skin rash

Skin rash

Other conditions that could case Skin rash

Skin rash

Can you answer these questions?

More questions for: Multiple sclerosis, Skin rash

You may be interested in these reviews

More reviews for: Multiple sclerosis, Skin rash


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.